Brain tumor registry using clinical and brain scan information
Part of Cancer clinical trials.
This study collects information about people with brain gliomas, including what treatments they receive and what their brain scans show. It’s meant to help researchers better understand these tumors and how they respond to first- or second-line therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a brain glioma confirmed by both imaging scans and tissue (biopsy/surgery) results
- Your expected survival is more than 3 months
- You are starting or receiving treatment that is your first or second major therapy option
- You can provide signed informed consent (or your legal representative can)
- You do not have an implanted device that can be affected by magnets, electricity, or similar signals (for example pacemakers or certain neurostimulators)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with lower-grade (WHO grade 2 or less) brain tumors using repeat MRI scans over time. It helps doctors understand how these tumors change and which patients may safely delay treatment at first.
This study records health details about adults who may have a low-grade glioma (a slower-growing brain tumor) based on scan results. Researchers use these data to better understand disease patterns and outcomes, and help connect individual patients to future research.
This trial uses a special MRI scan to study the genetics of gliomas (a type of brain tumor). It may help doctors better understand your tumor and choose the right treatment. You can join if you have a suspected or confirmed low- or high-grade glioma that still has a measurable tumor after surgery.
This is an observational study that collects and compares information from patients with primary brain tumors and their treatment results. It uses stored tumor tissue and brain scans to better understand outcomes using updated tumor classification methods.
This study collects medical information (and sometimes tumor tissue) from people diagnosed with certain brain tumors after January 1, 2012. It aims to improve understanding of these tumors worldwide so future care can be better.
This study is a patient registry for people with brain tumors who had surgery to remove as much as safely possible and then had GammaTiles placed. It mainly collects information and follow-up imaging to understand how patients do after the treatment.
Hear when a new Adult Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.